Literature DB >> 9257834

A solution to the rheumatoid factor paradox: pathologic rheumatoid factors can be tolerized by competition with natural rheumatoid factors.

J J Stewart1, H Agosto, S Litwin, J D Welsh, M Shlomchik, M Weigert, P E Seiden.   

Abstract

Rheumatoid factors (RF) associated with arthritic joint erosion are only seen transiently, if at all, in nondiseased individuals. Therefore, a tolerance mechanism must exist that prevents pathologic RF B cells from expressing Abs. Surprisingly, it has been shown that pathologic RF B cells are not tolerized by any previously established tolerance mechanism such as deletion, receptor editing, anergy, or prevention of memory establishment. How are pathologic RF cells tolerized? By simulating the RF response with a cellular automaton model immune system, we demonstrate that pathologic RFs can be tolerized by the novel mechanism of "competitive tolerance" with natural, nonpathologic RFs. We then demonstrate that competitive tolerance can be broken when a sequestered pool of expanding B cells are inappropriately subjected to chronic stimulation (as appears to occur in MRL/lpr mice and in patients with rheumatoid arthritis).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257834

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Systems immunology: a survey of modeling formalisms, applications and simulation tools.

Authors:  Vipin Narang; James Decraene; Shek-Yoon Wong; Bindu S Aiswarya; Andrew R Wasem; Shiang Rong Leong; Alexandre Gouaillard
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

2.  Histidine-rich glycoprotein prevents the formation of insoluble immune complexes by rheumatoid factor.

Authors:  N N Gorgani; J G Altin; C R Parish
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

3.  Agent-based modeling of host-pathogen systems: The successes and challenges.

Authors:  Amy L Bauer; Catherine A A Beauchemin; Alan S Perelson
Journal:  Inf Sci (N Y)       Date:  2009-04-29       Impact factor: 6.795

4.  A virtual look at Epstein-Barr virus infection: simulation mechanism.

Authors:  M Shapiro; K A Duca; K Lee; E Delgado-Eckert; J Hawkins; A S Jarrah; R Laubenbacher; N F Polys; V Hadinoto; D A Thorley-Lawson
Journal:  J Theor Biol       Date:  2008-02-16       Impact factor: 2.691

5.  Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies.

Authors:  M R Ehrenstein; H T Cook; M S Neuberger
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

Review 6.  Neutralization-Enhancing RF Antibodies for HIV Vaccines.

Authors:  Konstantin V Suslov
Journal:  Front Immunol       Date:  2014-12-16       Impact factor: 7.561

Review 7.  Histidine-rich glycoprotein (HRGP): Pleiotropic and paradoxical effects on macrophage, tumor microenvironment, angiogenesis, and other physiological and pathological processes.

Authors:  Yixiao Pan; Lu Deng; Hai Wang; Kang He; Qiang Xia
Journal:  Genes Dis       Date:  2020-08-08

Review 8.  Rheumatoid factors: clinical applications.

Authors:  Francesca Ingegnoli; Roberto Castelli; Roberta Gualtierotti
Journal:  Dis Markers       Date:  2013-11-13       Impact factor: 3.434

9.  Mouse models of lupus: what they tell us and what they don't.

Authors:  Mara Lennard Richard; Gary Gilkeson
Journal:  Lupus Sci Med       Date:  2018-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.